This Market access section features Market access companies, inc health economics; pricing and reimbursement.
ERT is passionate and committed about transforming the way you conduct your drug development and healthcare efforts. Understanding that you need the most accurate, cost-effective and convenient support systems to collect timely, regulatory-compliant data, our team of experts will work together with you to ensure joint success.
The GalbraithWight Business School deliver boths in-house and public training programmes including the only accredited diploma designed specifically to enable managers to lead or contribute effectively to cross functional brand teams at global, regional and local level.
Health Enterprise East Limited (HEE) is the NHS Innovation Hub for the East of England, and assists with accelerating the development and uptake of innovative MedTech products and services that improve the quality of healthcare delivery.
We are a fully independent, specialist healthcare company and our core business offers three specific services: Expert Panel and Advisory Board Services, Opinion Leader Identification and Advocacy Development and Strategic Healthcare Consulting.
'We have a habit of divine discontent with our performance.It is an antidote to smugness.'So said David Ogilvy. And so say us.To see the eight creative habits that make Ogilvy, Ogilvy, visit...
pharmaLevers GmbH is a Swiss based life science consulting firm in the area of Market Access (Pricing & Reimbursement, Health Economy, HTA and Policy).
PPi specialises in providing guidance and implementation services for healthcare provision. PPi supports the development of market access strategies as well as the ultimate implementation of such strategies. We accomplish this through our intimate understanding of country healthcare systems and our relationships with payers, physicians, pharmacists and other key stakeholders.
Founded in 2000, Policy Matters is a healthcare-dedicated, independent, market access consultancy that matches healthcare policy to business to help our clients benefit from the opportunities created by the changing NHS landscape. At Policy Matters we help our clients put market access at the heart of their marketing and market development activities and align the company and brand with customers' needs.
Consultancy service to the Pharmaceutical Industry on the strategy required to build Stakeholder Value into a product
PSS is one of the largest nhs medicines management providers in the UK. We work with a range of partners to deliver practice /ccg wide disease management proggrammes
Roboleo & Co is an independent, UK based consultancy focused on creating innovative, evidenced-based, Market Access solutions
RTI is an independent, nonprofit institute that provides research, development, and technical services to government and commercial clients worldwide. Our mission is to improve the human condition by turning knowledge into practice.
SG Market Access specialises in Payor NHS Reimbursement Research Integrated care consensus cost impact and steering groups
Selling to the UK National Health Service is challenging and time consuming. UK HealthGateway gives you the solutions and services to win sales.
Commercial opportunity assessments supported by key stakeholder research to understand the marketplace, competitors and product value
Consulting to the the health technology industry, we help achieve brand ambitions by optimizing how brands are appraised, positioned and commissioned into the health system.
Visions4health™ are an established healthcare network agency specialising in market access. We have a proven track record of redefining market access for our clients. Visions4health™
Mapping market access for success
YorkTown Access Personnel have years of experience within the pharmaceutical and medical device industry and are committed to providing innovative and game-changing programmes: Developing innovative and relevant communications for key decision makers associated with pharmaceutical and medical device/diagnostics market access and HEOR; Developing and writing single technology appraisals (STA) (pharmaceutical and medical device) for regulatory institutions (NICE, EMA, SMC and FDA); Developing payer facilitation communications associated with budget impact modelling: payer negotiation handlers and FAQs, reimbursement strategy; Design and preparation of high impact value dossiers; Preparation of government healthcare authority white papers for lobbying purposes and horizon scanning; KOL mapping and full MSL training programme; MSL and market access deployment strategies; Specialists in developing markets